T. Rowe Price Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.73M | Buy |
|
|||||
|
2025
Q1 | $6.24M | Sell |
|
|||||
|
2024
Q4 | $45.2M | Buy |
|
|||||
|
2024
Q3 | $14.9M | Buy |
|
|||||
|
2024
Q2 | $4.13M | Buy |
|
|||||
|
2024
Q1 | $2.85M | Buy |
|
|||||
|
2023
Q4 | $1.73M | Buy |
|
|||||
|
2023
Q3 | $1.55M | Buy |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $1.21M | Buy |
|
|||||
|
2022
Q4 | $1.14M | Buy |
|
|||||
|
2022
Q3 | $959K | Sell |
|
|||||
|
2022
Q2 | $5.41M | Buy |
|
|||||
|
2022
Q1 | $6.11M | Buy |
|
|||||
|
2021
Q4 | $4.28M | Buy |
|
|||||
|
2021
Q3 | $4.96M | Sell |
|
|||||
|
2021
Q2 | $5.13M | Buy |
|
|||||
|
2021
Q1 | $1.27M | Buy |
|
|||||
|
2020
Q4 | $1.02M | Buy |
|
|||||
|
2020
Q3 | $565K | Hold |
|
|||||
|
2020
Q2 | $773K | Buy |
|
|||||
|
2020
Q1 | $553K | Buy |
|
|||||
|
2019
Q4 | $293K | Buy |
|
|||||
|
2019
Q3 | $160K | Sell |
|
|||||
|
2019
Q2 | $88.2M | Buy |
|
|||||
|
2019
Q1 | $125M | Buy |
|
|||||
|
2018
Q4 | $106M | Buy |
|
|||||
|
2018
Q3 | $134M | Buy |
|
|||||
|
2018
Q2 | $141M | Buy |
|
|||||
|
2018
Q1 | $51.3M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $42.7M | Sell |
|
|||||
|
2017
Q1 | $153M | Sell |
|
|||||
|
2016
Q4 | $263M | Buy |
|
|||||
|
2016
Q3 | $290M | Buy |
|
|||||
|
2016
Q2 | $308M | Sell |
|
|||||
|
2016
Q1 | $343M | Buy |
|
|||||
|
2015
Q4 | $419M | Sell |
|
|||||
|
2015
Q3 | $398M | Sell |
|
|||||
|
2015
Q2 | $445M | Buy |
|
|||||
|
2015
Q1 | $462M | Buy |
|
|||||
|
2014
Q4 | $350M | Buy |
|
|||||
|
2014
Q3 | $286M | Buy |
|
|||||
|
2014
Q2 | $243M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $15.9M | Buy |
|